Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business - Seite 2

New Product Development

• Chewable Oat Beta Glucan (OBG):
  • Ceapro’s team has successfully developed a unique, standardized formulation for a healthy confection which includes a high concentration of OBG with daily dosage according to approved claims in 10 developed countries.
  • Health Canada has approved Ceapro’s Novel Nutraceutical Product (NPN 80127493). The substantive claims derived from this approval include reduction of LDL cholesterol, supporting cardiovascular health reduction of Type 2 diabetes risks, source of fiber for the maintenance of general good health and support of a healthy digestive system.
  • Ceapro’s team anticipates the official commercial launch of its approved natural health product in H2, 2024, marking an important chapter in the Company's journey toward promoting wellness while expanding its business model. According to Future Market Insights, the oat beta-glucan market is expected to reach US$ 846.1 Million in 2032.

• Whey Proteins:
  • Using its PGX Technology, Ceapro and University of Alberta researchers successfully processed in one economical step a very complex mixture containing animal-based proteins, and in particular whey proteins that are typically found in liquid that remains after cheese production. While these proteins are widely used in sport drinks, baked goods, meal replacements, protein supplements and infant formulas due to their recognized nutritional and functional properties, current commercial purification processes require many steps and considerable amounts of water. PGX Technology can be a very efficient and economical alternative for this product offering.
  • Results from this ground-breaking study were published in the Journal of Food Engineering in an article titled “Single-step concentration of whey proteins using the pressurized gas eXpanded (PGX) liquid technology: Effect on physicochemical properties and scale-up,”. They have also been submitted for a presentation at the 20^th European meeting on supercritical fluids in Maribor, Slovenia, May 26-29, 2024.
    

Technology

• Pressurized Gas eXpanded Technology (“PGX Technology”)
  • Edmonton Main Facility PGX Scale Up 50 Liters Vessel: The project remains on schedule. The mechanical part of the project is 100% completed and control systems are 80% completed. Pending receipt of remaining automation components, commissioning expected to be completed by end of Q1 2024.
  • Natex Facility, Austria PGX Scale Up 100 Liters Vessel: The project remains on schedule. PGX pressure vessel design is 100% completed. Initial safety and regulatory risk assessment has also been completed. Commissioning is expected to be completed by end of Q3 2024.